Machine learning-based causal models for predicting the response of individual patients to dexamethasone treatment as prophylactic antiemetic.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 05 2023
Historique:
received: 03 02 2022
accepted: 03 05 2023
medline: 11 5 2023
pubmed: 10 5 2023
entrez: 10 5 2023
Statut: epublish

Résumé

Risk-based strategies are widely used for decision making in the prophylaxis of postoperative nausea and vomiting (PONV), a major complication of general anesthesia. However, whether risk is associated with individual treatment effect remains uncertain. Here, we used machine learning-based algorithms for estimating the conditional average treatment effect (CATE) (double machine learning [DML], doubly robust [DR] learner, forest DML, and generalized random forest) to predict the treatment response heterogeneity of dexamethasone, the first choice for prophylactic antiemetics. Electronic health record data of 2026 adult patients who underwent general anesthesia from January to June 2020 were analyzed. The results indicated that only a small subset of patients respond to dexamethasone treatment, and many patients may be non-responders. Estimated CATE did not correlate with predicted risk, suggesting that risk may not be associated with individual treatment responses. The current study suggests that predicting treatment responders by CATE models may be more appropriate for clinical decision making than conventional risk-based strategy.

Identifiants

pubmed: 37161041
doi: 10.1038/s41598-023-34505-0
pii: 10.1038/s41598-023-34505-0
pmc: PMC10169123
doi:

Substances chimiques

Antiemetics 0
Gastrointestinal Agents 0
Dexamethasone 7S5I7G3JQL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7549

Informations de copyright

© 2023. The Author(s).

Références

Ann Intern Med. 1999 Mar 16;130(6):515-24
pubmed: 10075620
Anesth Analg. 2006 Jun;102(6):1884-98
pubmed: 16717343
Sci Rep. 2021 Apr 19;11(1):8423
pubmed: 33875707
BMJ. 2018 Dec 10;363:k4245
pubmed: 30530757
N Engl J Med. 2004 Jun 10;350(24):2441-51
pubmed: 15190136
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Sci Rep. 2022 Feb 2;12(1):1714
pubmed: 35110611
BMJ. 2011 Oct 03;343:d5888
pubmed: 21968126
Br J Anaesth. 2015 Feb;114(2):252-60
pubmed: 25274048
Anesth Analg. 1999 Sep;89(3):796-7
pubmed: 10475327
Br J Anaesth. 2012 Jun;108(6):961-5
pubmed: 22382396
Circulation. 2005 Sep 27;112(13):2017-21
pubmed: 16186438
Clin J Am Soc Nephrol. 2018 Jun 7;13(6):842-849
pubmed: 29599299
Anesthesiology. 2018 Oct;129(4):663-674
pubmed: 29894315
Anesthesiology. 2000 Apr;92(4):958-67
pubmed: 10754614
Anesth Analg. 2013 Jan;116(1):58-74
pubmed: 23223115
JAMA Netw Open. 2019 Mar 1;2(3):e190005
pubmed: 30848803
Sci Rep. 2020 Jun 8;10(1):9219
pubmed: 32514028
Br J Anaesth. 1993 Aug;71(2):296-7
pubmed: 8123411
Anesth Analg. 2020 Aug;131(2):411-448
pubmed: 32467512
JAMA Netw Open. 2021 Jan 4;4(1):e2030913
pubmed: 33416883
Br J Anaesth. 2000 Jan;84(1):6-10
pubmed: 10740539
JAMA Netw Open. 2021 Mar 1;4(3):e212240
pubmed: 33783520
Br J Anaesth. 2018 Jan;120(1):156-163
pubmed: 29397124
Eur Heart J. 2002 Feb;23(3):223-9
pubmed: 11792137
Anesthesiology. 1999 Sep;91(3):693-700
pubmed: 10485781
BMJ. 2015 Feb 19;350:h454
pubmed: 25697494
JAMA Netw Open. 2020 Dec 1;3(12):e2029050
pubmed: 33301017
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232
pubmed: 30894318
Am J Prev Med. 2022 Apr;62(4):558-566
pubmed: 34810041
Sci Adv. 2021 Oct;7(40):eabj2610
pubmed: 34586850

Auteurs

Taisuke Mizuguchi (T)

Department of Anesthesia, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan. mizuguchi@med.teikyo-u.ac.jp.

Shigehito Sawamura (S)

Department of Anesthesia, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH